2025421|t|Potassium channel blockers: could they work in Alzheimer disease?
2025421|a|Many of the actions of potassium channel blockers, such as 4-aminopyridine, appear to complement the deficits in Alzheimer disease. The two clinical studies in the literature are contradictory, so potassium channel blockers may still merit trial in Alzheimer disease.
2025421	47	64	Alzheimer disease	Disease	MESH:D000544
2025421	125	140	4-aminopyridine	Chemical	MESH:D015761
2025421	179	196	Alzheimer disease	Disease	MESH:D000544
2025421	315	332	Alzheimer disease	Disease	MESH:D000544
2025421	Negative_Correlation	MESH:D015761	MESH:D000544

